FDBK Insider Trading

Insider Ownership Percentage: 10.75%
Insider Buying (Last 12 Months): GBX 0
Insider Selling (Last 12 Months): £4,046.40

Feedback Insider Trading History Chart

This chart shows the insider buying and selling history at Feedback by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Feedback Share Price & Price History

Current Price: GBX 19.78
Price Change: Price Decrease of -0.02 (-0.10%)
As of 01/21/2025 12:15 PM ET

This chart shows the closing price history over time for FDBK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Feedback Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/29/2024Philipp PrinceInsiderSell20,232GBX 20£4,046.40
10/25/2023Annemijn EschauzierInsiderSell5,422GBX 8,710£472,256.20
12/21/2022Philipp PrinceInsiderBuy4,531GBX 90£4,077.90
See Full Table

SEC Filings (Institutional Ownership Changes) for Feedback (LON:FDBK)

53.22% of Feedback stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Feedback logo
Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical. Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients. By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers. Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker® is a patient-facing platform that gives patients access and control over their diagnostic and other clinical data. The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.
Read More on Feedback

Today's Range

Now: GBX 19.78
Low: 19.60
High: 20

50 Day Range

MA: GBX 18.93
Low: 16.55
High: 20.67

52 Week Range

Now: GBX 19.78
Low: 16
High: 152.92

Volume

173,195 shs

Average Volume

230,735 shs

Market Capitalization

£2.64 million

P/E Ratio

N/A

Dividend Yield

4.56%

Beta

0.77

Who are the company insiders with the largest holdings of Feedback?

Feedback's top insider shareholders include:
  1. Annemijn Eschauzier (Insider)
  2. Philipp Prince (Insider)
Learn More about top insider investors at Feedback.